Ankle Fracture (Trimalleolar)MANAGEMENT

MUSCULOSKELETAL AND RHEUMATOLOGIC PRESENTATIONS · 12 SECTIONS

⚲

547 items

☷ Legend

01Approach to the Critical Patient/attcp55

Immediate priorities

›Limb-threat triage

›Fracture-dislocation with deformity

›Gross malalignment of the mortise

›Rapid tense swelling

›Skin tenting over malleoli

›Anteromedial necrosis risk 17.6% when splinted with loss of reduction

›Pressure blanching of skin

›If fracture-dislocation with tenting, immediate closed reduction

›Time-sensitive to prevent skin necrosis

›Reassess neurovascular status after reduction

›Neurovascular threats

›Pulse deficit

›Absent dorsalis pedis pulse

›Absent posterior tibial pulse

›Perfusion failure

›Foot pallor or cyanosis

›Prolonged capillary refill

›If pulse absent after reduction, vascular surgery activation

›Repeat reduction attempt first

›Consider CT angiography of the limb

›Open fracture recognition

›Skin breach over fracture

›Bone exposure

›Wound communicating with fracture hematoma

›If open, emergent irrigation and antibiotics

›Cefazolin within 1 hour

›Tetanus status review

02History/hx61

Mechanism and presentation

›Injury mechanism

›Rotational or twisting force

›Low-energy simple fall or twist

›Inversion or eversion with axial load

›High-energy mechanism

›Fall from height

›Motor vehicle collision

›Position of foot at injury

›Witnessed deformity at scene

›Audible pop or snap

›Symptom characterization

›Immediate inability to bear weight

›Severe pain at onset

›Rapid swelling

›Timing of injury

›Exact time critical for surgical planning

›Duration of swelling guides soft-tissue management

›Neurologic symptoms

›Numbness or tingling in foot

›Weakness of toe dorsiflexion

Important negatives and clues

›Associated injury screen

›Proximal fibula pain

›Maisonneuve fracture concern

›Syndesmotic disruption

›Ipsilateral knee or foot pain

›Fifth metatarsal base fracture

03Physical Exam/exam52

Inspection and vitals

›Inspection

›Gross deformity

›Visible malalignment

›Dislocation pattern

›Soft tissue compromise

›Anteromedial skin tenting

›Fracture blisters

›Open wounds

›Bleeding from fracture site

›Visible bone

›Vital signs

›Tachycardia

›Pain driven

›Blood loss in polytrauma

›Hypotension

›Polytrauma source evaluation

›Reassess after analgesia

Palpation and neurovascular

›Palpation

›Three malleoli tenderness

›Lateral malleolus

›Medial malleolus

›Posterior malleolus region

›Proximal fibula

›Maisonneuve screen along entire fibula

›Squeeze test reproducing distal pain

›Adjacent structures

04Differential Diagnosis/ddx31

Fracture pattern differentials

›Ankle fracture spectrum

›Trimalleolar fracture

›ICD-10 S82.853

›Lateral, medial, and posterior malleoli involved

›Bimalleolar fracture

›No posterior malleolus involvement

›Distinguish on lateral radiograph

›Maisonneuve fracture

›Proximal fibula fracture

›Medial malleolus with syndesmotic disruption

›Higher-energy patterns

›Pilon fracture

›Axial load mechanism

›Comminution of distal tibial plafond

›Talar fracture

›Often coexists

›Best seen on CT or MRI

Soft-tissue and mimics

›Ligamentous and tendon injury

›Ankle dislocation without fracture

›Pure ligamentous injury

›Rare presentation

›Achilles tendon rupture

›Positive Thompson test

›No bony tenderness

›Osseous mimics

›Osteochondral lesion of talus

05Laboratory Tests/lt27

Preoperative panel

›Routine surgical labs

›Complete blood count

›Baseline hemoglobin

›Leukocytosis if infection concern

›Basic metabolic panel

›Renal function for contrast and dosing

›Electrolyte status

›Coagulation studies

›INR for anticoagulated patients

›Baseline before surgery

›Type and screen

›Surgical candidate preparation

›Anticipated blood loss

Risk and optimization labs

›VTE risk markers

›D-dimer

›Consider if DVT suspected preoperatively

›Independent risk factor when elevated

›Albumin

›Low albumin linked to wound complications

›Associated with DVT risk

›Metabolic optimization

›HbA1c

›Diabetic glycemic assessment

›Perioperative glucose control reduces infection

›Pregnancy test

›Women of childbearing age

06Diagnostic Tests/dt69

Scoring Systems

›Ottawa Ankle Rules

›Bone tenderness criteria

›Posterior distal 6 cm of tibia

›Posterior distal 6 cm of fibula

›Tip of either malleolus

›Functional criterion

›Inability to bear weight immediately and in ED

›Four steps test

›Performance

›Sensitivity 92 to 99 percent for fracture

›Trimalleolar fractures virtually always meet criteria

›Classification systems

›AO/OTA classification

›Highest overall reliability kappa 0.86

›Guides fixation strategy

›Bartonicek classification

›Most reliable for posterior malleolus kappa 0.78

›CT-based morphology

›Lauge-Hansen and Danis-Weber

›Mechanism-based description

›Weber level relative to syndesmosis

›TRiP(cast) score

›VTE risk stratification in limb immobilization

›Bimalleolar or trimalleolar fracture scores 2 points

›Intermediate risk category

›Threshold interpretation

›Score 7 or higher warrants thromboprophylaxis

07Disposition/dispo37

Admission and observation

›Admission indications

›Fracture-dislocation requiring monitoring

›Risk of redislocation

›Soft-tissue compromise

›Open fracture or neurovascular compromise

›Emergent operative need

›Vascular consultation

›Compartment syndrome concern

›Serial pressure monitoring

›Fasciotomy readiness

›Significant comorbidity

›Congestive heart failure

›Coagulopathy or peripheral vascular disease

›Observation pathway

›Post-reduction monitoring

›Neurovascular checks every 1 to 2 hours

›24 to 48 hours if compartment risk

›Reduction maintenance

›Post-reduction films

›Splint integrity check

Discharge and follow-up

›Discharge criteria

›Stable reduction maintained

›Acceptable post-reduction radiographs

›Mortise alignment preserved

›Intact neurovascular exam

›Palpable pulses

08Treatment/t85

ED stabilization

›Reduction

›Indication

›Fracture-dislocation present

›Skin tenting or neurovascular compromise

›Technique

›Longitudinal traction with recreation then reversal of mechanism

›Confirm with post-reduction films

›If reduction lost, repeat and reassess soft tissue

›50 percent redislocation with splinting alone

›Consider external fixation

›Splinting

›Well-padded posterior splint

›Sugar-tong or stirrup component

›Neutral dorsiflexion after reduction

›Adjuncts

›Ice over splint

›Strict non-weight-bearing and elevation

Analgesia

›Intra-articular hematoma block

›Technique

›10 to 20 mL of 1 percent lidocaine into ankle joint

›First-line for closed reduction of subluxation

›Evidence

›Analgesia comparable to procedural sedation

›Shorter ED time than sedation

›Procedural sedation

›Agents

09Special Populations/sp39

Pregnancy

›Pregnancy considerations

›Imaging approach

›Abdominal shielding for ankle radiographs

›Limit CT to essential operative planning

›Analgesia selection

›Acetaminophen preferred

›Avoid NSAIDs in third trimester

›Anesthetic and VTE

›Regional anesthesia consideration

›Increased baseline VTE risk warrants prophylaxis review

›Positioning

›Left lateral tilt when supine

›Avoid aortocaval compression

Geriatric

›Older adult features

›Fragility fracture context

›Low-energy mechanism

›Osteoporosis evaluation

›Higher complication risk

›Diabetes and vascular disease prevalence

›Wound healing impairment

›Medication considerations

›Renal dosing of LMWH

›Reduced opioid dosing

›Disposition bias

›Limited home support

›Frailty and fall risk

10Background/b60

Epidemiology

›Frequency and burden

›Proportion of ankle fractures

›Trimalleolar represents about 7 percent

›Highest complication rates among subtypes

›Demographic distribution

›Young males from sports

›Older females from osteoporotic falls

›Long-term outcome

›30 percent report inferior function at 15 to 22 years

›Hardware removal in about 17 percent within 3 years

›Complication rates

›Infection

›Approximately 4.4 percent after ORIF

›Higher with diabetes

›Thromboembolism

›1.6 to 3 percent of operative cases

›Preoperative DVT 6.4 percent

›Mechanical complications

›Approximately 0.4 percent

›Post-traumatic arthritis over time

Pathophysiology

›Mortise instability

›Three-column disruption

›Lateral malleolus

›Medial malleolus

›Posterior malleolus

›Talar shift

11Patient Discharge Instructions/pdi19

copy discharge instructions

›Splint and weight-bearing care

›Strict non-weight-bearing on the injured leg

›Keep leg elevated above heart level

›Do not remove or modify the splint

›Wiggle toes frequently to maintain circulation

›Pain and swelling control

›Ice 20 minutes on and off over the splint

›Take pain medication as prescribed

›Take blood thinner exactly as prescribed if given

›Warning signs to return to ER

›Increasing pain despite elevation and medication

›Numbness or color change in the toes

›Splint becoming too tight or too loose

›Fever or drainage from any wound

›Calf swelling, warmth, or new shortness of breath

›Follow-up plan

›Orthopedic surgery appointment within 5 to 7 days

›Surgery typically within 1 to 2 weeks once swelling subsides

›Full recovery commonly 3 to 6 months

12References/r12

Guidelines and key sources

›Guideline and consensus sources

›ACR Appropriateness Criteria acute trauma to the ankle

›American College of Surgeons best practices in orthopedic trauma

›Western Trauma Association VTE prevention algorithm

›Landmark trials and studies

›PREVENT CLOT aspirin versus LMWH for fracture thromboprophylaxis

›TRiP(cast) stepped-wedge implementation trial for targeted prophylaxis

›Intra-articular hematoma block versus procedural sedation trials

›Decision tools and coding

›Ottawa Ankle Rules clinical decision rule

›ICD-10 S82.853 for displaced trimalleolar fracture

›AO/OTA and Bartonicek classification systems

Learn More: Ankle Fracture (Trimalleolar)→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.